Efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with extremely high lipoprotein(a) levels >180 mg/dL

Cardiovascular Therapy and Prevention (Russian Federation) · Published 2026-07-31 · DOI 10.15829/1728-8800-2026-4744

Free full text

Authors (9)

G. A. Konovalov, M. G. Chashchin, Z. I. Khutaeva, M. B. Mukhtarov, Z. M. Musaeva, H. A. Khashieva, V. S. Rabicheva, A. Yu. Gorshkov, O. M. Drapkina

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Konovalov, G., Chashchin, M., Khutaeva, Z., et al. (2026). Efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with extremely high lipoprotein(a) levels >180 mg/dL. Cardiovascular Therapy and Prevention (Russian Federation). https://doi.org/10.15829/1728-8800-2026-4744

Related articles